| Literature DB >> 31930094 |
Yu-Chin Huang1,2, Liang-Chuan Lai1,3.
Abstract
Extracellular vesicles (EVs) of mesenchymal stem cells (MSCs) are secreted by live cells and possess the same regenerative potential and immunomodulatory ability as their parental cells. Clinical applications of MSC-EVs could overcome the shortage of MSCs for treatment of cancer and other diseases and impact the field of regenerative medicine from cellular to acellular therapy. For use of MSC-EVs as a clinical agent, various engineered EVs have been manufactured and their therapeutic effects on various diseases demonstrated in preclinical studies and clinical trials. However, MSC-EVs are heterogeneous, and many of their characteristics are still unknown. Many barriers still need to be surmounted before MSC-EVs can be used as biomedical agents. 2019 Annals of Translational Medicine. All rights reserved.Entities:
Keywords: Mesenchymal stem cell (MSC); extracellular vesicle (EV); therapeutic tool
Year: 2019 PMID: 31930094 PMCID: PMC6944607 DOI: 10.21037/atm.2019.11.66
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839